Literature DB >> 16322499

Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?

C S Rivers1, J M Wardlaw, P A Armitage, M E Bastin, T K Carpenter, V Cvoro, P J Hand, M S Dennis.   

Abstract

BACKGROUND AND
PURPOSE: An acute mismatch on diffusion-weighted MRI (DWI) and perfusion-weighted MRI (PWI) may represent the "tissue-at-risk." It is unclear which "semiquantitative" perfusion parameter most closely identifies final infarct volume.
METHODS: Acute stroke patients underwent DWI and PWI (dynamic-susceptibility contrast imaging) on admission (baseline), and T2-weighted imaging (T2WI) at 1 or 3 months after stroke. "Semiquantitative" mean transit time (MTTsq=first moment of concentration/time curve), cerebral blood volume (CBVsq=area under concentration/time curve), and cerebral blood flow (CBFsq=CBVsq/MTTsq) were calculated. DWI and PWI lesions were measured at baseline and final infarct volume on T2WI acquired > or =1 month after stroke. Baseline DWI, CBFsq, and MTTsq lesion volumes were compared with final T2WI lesion volume.
RESULTS: Among 46 patients, baseline DWI and CBFsq lesions were not significantly different from final T2WI lesion volume, but baseline MTTsq lesions were significantly larger. The correlation with final T2WI lesion volume was strongest for DWI (Spearman rank correlation coefficient rho=0.68), intermediate for CBFsq (rho=0.55), and weakest for MTTsq (rho=0.49) baseline lesion volumes. Neither DWI/CBFsq nor DWI/MTTsq mismatch predicted lesion growth; lesion growth was equally common in those with and without mismatch.
CONCLUSIONS: Of the 2 PWI parameters, CBFsq lesions most closely identifies, and MTTsq overestimates, final T2WI lesion volume. "DWI/PWI mismatch" does not identify lesion growth. Patients without "DWI/PWI mismatch" are equally likely to have lesion growth as those with mismatch and should not be excluded from acute stroke treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16322499     DOI: 10.1161/01.STR.0000195197.66606.bb

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  42 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  Arterial spin labeling at 3.0 Tesla in subacute ischemia: comparison to dynamic susceptibility perfusion.

Authors:  S Huck; H U Kerl; M Al-Zghloul; C Groden; I Nölte
Journal:  Clin Neuroradiol       Date:  2012-01-20       Impact factor: 3.649

3.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

4.  The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent.

Authors:  Bruce C V Campbell; Archana Purushotham; Soren Christensen; Patricia M Desmond; Yoshinari Nagakane; Mark W Parsons; Maarten G Lansberg; Michael Mlynash; Matus Straka; Deidre A De Silva; Jean-Marc Olivot; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-20       Impact factor: 6.200

5.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

6.  Transit time homogenization in ischemic stroke - A novel biomarker of penumbral microvascular failure?

Authors:  Thorbjørn S Engedal; Niels Hjort; Kristina D Hougaard; Claus Z Simonsen; Grethe Andersen; Irene Klærke Mikkelsen; Jens K Boldsen; Simon F Eskildsen; Mikkel B Hansen; Hugo Angleys; Sune N Jespersen; Salvador Pedraza; Tae H Cho; Joaquín Serena; Susanne Siemonsen; Götz Thomalla; Norbert Nighoghossian; Jens Fiehler; Kim Mouridsen; Leif Østergaard
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-31       Impact factor: 6.200

7.  Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.

Authors:  Anna Tietze; Jakob Blicher; Irene Klaerke Mikkelsen; Leif Østergaard; Megan K Strother; Seth A Smith; Manus J Donahue
Journal:  NMR Biomed       Date:  2013-11-28       Impact factor: 4.044

8.  Susceptibility-weighted imaging predicts infarct size and early-stage clinical prognosis in acute ischemic stroke.

Authors:  Song Luo; Lijuan Yang; Yanfei Luo
Journal:  Neurol Sci       Date:  2018-03-20       Impact factor: 3.307

9.  Correlating tissue outcome with quantitative multiparametric MRI of acute cerebral ischemia in rats.

Authors:  Kimmo T Jokivarsi; Yrjö Hiltunen; Pasi I Tuunanen; Risto A Kauppinen; Olli H J Gröhn
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE.

Authors:  Maarten G Lansberg; Vincent N Thijs; Scott Hamilton; Gottfried Schlaug; Roland Bammer; Stephanie Kemp; Gregory W Albers
Journal:  Stroke       Date:  2007-05-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.